Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

: Saglio G, Kim D-W, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, et al., for the ENESTnd Investigators, Remes K

: 2010

: New England Journal of Medicine

: 24

: 362

: 24

: 2251

: 2259

: 9

: 0028-4793

DOI: https://doi.org/10.1056/NEJMoa0912614